Page last updated: 2024-09-04

docetaxel anhydrous and Vascular Diseases

docetaxel anhydrous has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assayag, F; Berniard, A; Beuzeboc, P; Dahmani, A; de Plater, L; Decaudin, D; Fontaine, JJ; Guyader, C; Marangoni, E; Némati, F; Oudard, S; Pasik, C; Poupon, MF	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Vascular Diseases

Article	Year
A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer. Anti-cancer drugs, 2010, Volume: 21, Issue:10 Topics: Aged; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Docetaxel; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Estramustine; Gastrointestinal Diseases; Humans; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Taxoids; Vascular Diseases; Venous Thrombosis; Xenograft Model Antitumor Assays	2010

Article

Year

A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.

Anti-cancer drugs, 2010, Volume: 21, Issue:10

Topics: Aged; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Docetaxel; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Estramustine; Gastrointestinal Diseases; Humans; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Taxoids; Vascular Diseases; Venous Thrombosis; Xenograft Model Antitumor Assays

2010